Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Inventory (2016 - 2025)

Historic Inventory for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $922.0 million.

  • Resmed's Inventory rose 452.8% to $922.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $922.0 million, marking a year-over-year increase of 452.8%. This contributed to the annual value of $927.7 million for FY2025, which is 1282.59% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Inventory is $922.0 million, which was up 452.8% from $945.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Inventory registered a high of $1.0 billion during Q1 2023, and its lowest value of $457.0 million during Q2 2021.
  • In the last 5 years, Resmed's Inventory had a median value of $873.5 million in 2022 and averaged $815.7 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 7070.21% in 2022, then tumbled by 1797.85% in 2024.
  • Quarter analysis of 5 years shows Resmed's Inventory stood at $592.1 million in 2021, then skyrocketed by 67.01% to $989.0 million in 2022, then fell by 5.64% to $933.2 million in 2023, then fell by 5.48% to $882.1 million in 2024, then grew by 4.53% to $922.0 million in 2025.
  • Its last three reported values are $922.0 million in Q4 2025, $945.8 million for Q3 2025, and $927.7 million during Q2 2025.